ESCQX | NAESX | ESCQX / NAESX | |
Total Expense Ratio | 0.61 | 0.17 | 359% |
Annual Report Gross Expense Ratio | 0.65 | 0.17 | 382% |
Fund Existence | 2 years | 65 years | - |
Gain YTD | 6.136 | 7.684 | 80% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 543M | 162B | 0% |
Annual Yield % from dividends | 0.36 | 1.23 | 29% |
Returns for 1 year | 7.62 | 10.42 | 73% |
Returns for 3 years | N/A | 48.54 | - |
Returns for 5 years | N/A | 58.94 | - |
Returns for 10 years | N/A | 133.72 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IGD | 5.84 | 0.01 | +0.17% |
Voya Global Equity Dividend AND Premium Opportunity Fund | |||
MBCC | 37.01 | -0.11 | -0.31% |
Monarch Blue Chips Core ETF | |||
SUSA | 136.19 | -0.80 | -0.58% |
iShares ESG Optimized MSCI USA ETF | |||
BBC | 28.00 | -0.17 | -0.59% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
TSYY | 8.14 | -0.14 | -1.69% |
GraniteShares YieldBOOST TSLA ETF |